Scarica l'app Stockscreener
4.46
7.17%
-0.35
Precedente Chiudi:
$4.81
Aprire:
$4.86
Volume 24 ore:
130.04K
Relative Volume:
0.43
Capitalizzazione di mercato:
$93.59M
Reddito:
-
Utile/perdita netta:
$-94.11M
Rapporto P/E:
-0.7421
EPS:
-6.01
Flusso di cassa netto:
$-86.06M
1 W Prestazione:
-15.75%
1M Prestazione:
+47.85%
6M Prestazione:
+30.17%
1 anno Prestazione:
-41.63%
Intervallo 1D:
$4.46
$4.945
Intervallo di 1 settimana:
$4.46
$5.59
Portata 52W:
$1.78
$8.56
Adverum Biotechnologies Inc Stock (ADVM) Company Profile
Nome
Adverum Biotechnologies Inc
Settore
Industria
Telefono
(650) 649-1004
Indirizzo
100 CARDINAL WAY, REDWOOD CITY, CA
Confronta ADVM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ADVM
Adverum Biotechnologies Inc
|
4.46 | 100.93M | 0 | -94.11M | -86.06M | -6.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.38 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.30 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.68 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
801.92 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
331.34 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Adverum Biotechnologies Inc Stock (ADVM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-25 | Iniziato | Oppenheimer | Outperform |
| 2024-04-30 | Iniziato | H.C. Wainwright | Buy |
| 2022-07-07 | Aggiornamento | Truist | Hold → Buy |
| 2021-07-23 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-05-03 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-04-29 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2021-04-29 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-04-29 | Downgrade | Truist | Buy → Hold |
| 2020-12-16 | Iniziato | UBS | Neutral |
| 2020-11-12 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2020-06-26 | Downgrade | Raymond James | Mkt Perform → Underperform |
| 2020-05-13 | Iniziato | RBC Capital Mkts | Outperform |
| 2020-05-05 | Aggiornamento | SunTrust | Hold → Buy |
| 2020-04-28 | Iniziato | Goldman | Buy |
| 2020-03-16 | Iniziato | SVB Leerink | Outperform |
| 2020-02-10 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2020-02-10 | Aggiornamento | Chardan Capital Markets | Neutral → Buy |
| 2019-10-15 | Reiterato | Chardan Capital Markets | Neutral |
| 2019-09-13 | Reiterato | Chardan Capital Markets | Neutral |
| 2019-06-14 | Ripresa | Raymond James | Mkt Perform |
| 2018-11-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2018-11-02 | Downgrade | SunTrust | Buy → Hold |
| 2018-09-21 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-08-30 | Iniziato | SunTrust | Buy |
| 2018-02-15 | Ripresa | Piper Jaffray | Overweight |
| 2017-10-12 | Iniziato | Raymond James | Outperform |
Mostra tutto
Adverum Biotechnologies Inc Borsa (ADVM) Ultime notizie
Does Adverum Biotechnologies Inc. fit your quant trading model2025 Pullback Review & Real-Time Stock Price Movement Reports - newser.com
Analyzing recovery setups for Adverum Biotechnologies Inc. investorsShare Buyback & Real-Time Volume Spike Alerts - newser.com
Is Adverum Biotechnologies Inc. stock attractive for growth ETFs2025 Earnings Impact & Safe Capital Allocation Plans - newser.com
Real time social sentiment graph for Adverum Biotechnologies Inc.GDP Growth & Reliable Intraday Trade Plans - newser.com
What’s the recovery path for long term holders of Adverum Biotechnologies Inc.2025 Institutional Moves & High Yield Stock Recommendations - newser.com
Using RSI to spot recovery in Adverum Biotechnologies Inc.2025 Risk Factors & Growth Focused Investment Plans - newser.com
Can Adverum Biotechnologies Inc. (AVU0) stock sustain revenue momentumGap Up & Smart Allocation Stock Tips - newser.com
Price action breakdown for Adverum Biotechnologies Inc.2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Can Adverum Biotechnologies Inc. recover in the next quarterAnalyst Upgrade & Expert Curated Trade Setups - newser.com
Adverum Biotechnologies Inc.’s volatility index tracking explainedFed Meeting & High Conviction Trade Alerts - newser.com
Adverum Biotechnologies (NASDAQ:ADVM) Stock Passes Above 50-Day Moving AverageWhat's Next? - MarketBeat
Visual trend scoring systems applied to Adverum Biotechnologies Inc.Market Sentiment Review & Long-Term Capital Growth Strategies - newser.com
Short interest data insights for Adverum Biotechnologies Inc.Earnings Overview Summary & Safe Entry Trade Signal Reports - newser.com
Adverum Biotechnologies' (ADVM) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Is Adverum Biotechnologies Inc. (AVU0) stock a buy during volatile marketsGlobal Markets & Technical Buy Zone Confirmations - newser.com
Will Adverum Biotechnologies Inc. stock gain from lower inflationWeekly Trend Report & Long-Term Growth Stock Strategies - newser.com
Does Adverum Biotechnologies Inc. (AVU0) stock trade below intrinsic valueJuly 2025 Trade Ideas & Fast Gaining Stock Reports - newser.com
Using data filters to optimize entry into Adverum Biotechnologies Inc.July 2025 Summary & Verified Technical Signals - newser.com
Adverum Biotechnologies Inc Stock Analysis and ForecastShort Interest Overview & Explosive Profit Potential - earlytimes.in
What technical models suggest about Adverum Biotechnologies Inc.’s comebackWeekly Profit Analysis & Free Expert Approved Momentum Trade Ideas - newser.com
What MACD trends signal for Adverum Biotechnologies Inc. (AVU0) stockJuly 2025 Spike Watch & Technical Pattern Based Buy Signals - newser.com
Will Adverum Biotechnologies Inc. stock return to pre crisis levelsJuly 2025 Sentiment & Weekly Market Pulse Alerts - newser.com
Should you wait for a breakout in Adverum Biotechnologies Inc.July 2025 Technicals & Real-Time Stock Movement Alerts - newser.com
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Will Adverum Biotechnologies Inc. stock go up soon2025 AllTime Highs & Safe Capital Growth Tips - newser.com
After losing 28% in the past year, Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners must be relieved by the recent gain - simplywall.st
Adverum Biotechnologies, Inc. (NASDAQ:ADVM) institutional owners may be pleased with recent gains after 28% loss over the past year - Yahoo Finance
What drives Adverum Biotechnologies Inc stock priceInstitutional Holding Changes & Smarter Trades Backed by Machine Learning - earlytimes.in
Applying chart zones and confluence areas to Adverum Biotechnologies Inc.Volume Spike & Daily Growth Stock Tips - newser.com
Adverum Biotechnologies (NASDAQ:ADVM) Shares Cross Above Fifty Day Moving AverageHere's What Happened - MarketBeat
Adverum Biotechnologies Inc Azioni (ADVM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Adverum Biotechnologies Inc Azioni (ADVM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Seyedkazemi Setareh | CHIEF DEVELOPMENT OFFICER |
May 15 '25 |
Sale |
2.00 |
924 |
1,848 |
13,768 |
| Fischer Laurent | CEO, PRESIDENT AND DIRECTOR |
May 15 '25 |
Sale |
2.00 |
9,126 |
18,252 |
87,488 |
| Leonard Braden Michael | 10% Owner |
Mar 26 '25 |
Buy |
5.04 |
20,407 |
102,841 |
125,207 |
| Leonard Braden Michael | 10% Owner |
Mar 27 '25 |
Buy |
5.19 |
16,593 |
86,089 |
141,800 |
| Leonard Braden Michael | 10% Owner |
Apr 22 '25 |
Buy |
3.00 |
300,000 |
900,000 |
3,057,526 |
| Leonard Braden Michael | 10% Owner |
Apr 23 '25 |
Buy |
2.98 |
50,000 |
148,950 |
191,800 |
| Leonard Braden Michael | 10% Owner |
Mar 31 '25 |
Buy |
4.38 |
19,566 |
85,668 |
2,742,317 |
| Leonard Braden Michael | 10% Owner |
Apr 02 '25 |
Buy |
4.04 |
15,209 |
61,408 |
2,757,526 |
| Leonard Braden Michael | 10% Owner |
Mar 26 '25 |
Buy |
5.04 |
20,407 |
102,841 |
125,207 |
| Leonard Braden Michael | 10% Owner |
Mar 18 '25 |
Buy |
4.69 |
62,341 |
292,418 |
2,667,161 |
1.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):